Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Learn about Who Can Prescribe GLP-1 and how to access these medications safely
In the Liraglutide Efficacy and Action in Diabetes (LEAD) programme (61), a total of 154 patients with T2D within the LEAD-2 trial participated in a sub-study to assess liver fat content by the liver-to-spleen attenuation ratio at a computer tomography (CT) scan
If you experience any of these, contact your healthcare provider immediately
Once you stop, those effects fade and your body gradually resets
The efficacy and safety of tirzepatide, with a special focus on cardiovascular safety, were investigated in the 52-week SURPASS-4 trial testing tirzepatide versus insulin glargine in adults with T2D and a high cardiovascular risk under inadequate glycemic control at baseline on one to three oral glucose-lowering medications (metformin, sulfonylurea, SGLT-2 inhibitor) (74)
At this time, retatrutide is still being tested in clinical trials
US$ 28.40
US$ 23.14
US$ 22.75
